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The purpose of this chapter is to assist in the use and interpretation
of intrapartum cardiotocography (CTG), as well as in the clinical man-
agement of speciﬁc CTG patterns. In the preparation of these guidelines,
it has been assumed that all necessary resources, both human and ma-
terial, required for intrapartum monitoring and clinical management
are readily available. Unexpected complications may occur during
labor, even in patients without prior evidence of risk, so maternity hos-
pitals need to ensure the presence of trained staff, as well as appropriate
facilities and equipment for an expedite delivery (in particular emer-
gency cesarean delivery). CTG monitoring should never be regarded as
a substitute for good clinical observation and judgement, or as an excuse
for leaving the mother unattended during labor.2. Indications
The evidence for the beneﬁts of continuous CTG monitoring, as
compared with intermittent auscultation, in both low- and high-risk
labors is scientiﬁcally inconclusive [1,2].When comparedwith intermit-
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on the incidence of overall perinatalmortality or cerebral palsy. Howev-
er, these studies were carried out in the 1970s, 1980s, and early 1990s
where equipment, clinical experience, and interpretation criteria were
very different from current practice, and they were clearly underpow-
ered to evaluate differences in major outcomes [3]. These issues are
discussed in more detail in Section 8 of this chapter. In spite of these
limitations, most experts believe that continuous CTG monitoring
should be considered in all situations where there is a high risk of fetal
hypoxia/acidosis, whether due to maternal health conditions (such as
vaginal hemorrhage and maternal pyrexia), abnormal fetal growth
during pregnancy, epidural analgesia, meconium stained liquor, or the
possibility of excessive uterine activity, as occurs with induced or aug-
mented labor. Continuous CTG is also recommended when abnormali-
ties are detected during intermittent fetal auscultation. The use of
continuous intrapartum CTG in low-risk women is more controversial,
although it has become standard of care in many countries. An alterna-
tive approach is to provide intermittent CTG monitoring alternating
with fetal heart rate (FHR) auscultation. There is some evidence to sup-
port that this is associated with similar neonatal outcomes in low-risk
pregnancies [4]. Intermittent monitoring should be carried out long
enough to allow adequate evaluation of the basic CTG features (see
below). The routine use of admission CTG for low-risk women on en-
trance to the labor ward has been associated with an increase in cesar-
ean delivery rates and no improvement in perinatal outcomes [5], but
studies were also underpowered to show such differences. In spite of
the lack of evidence regarding beneﬁt, this procedure has also become
standard of care in many countries.
3. Tracing acquisition
3.1. Maternal position for CTG acquisition
Maternal supine recumbent position can result in aortocaval com-
pression by the pregnant uterus, affecting placental perfusion and fetal
oxygenation. Prolonged monitoring in this position should therefore
be avoided. The lateral recumbent, half-sitting, and upright positions
are preferable alternatives [6].
CTG acquisition can be performed by portable sensors that transmit
signals wirelessly to a remote fetal monitor (telemetry). This solutionynecology and Obstetrics.
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acquisition, rather than be restrained to bed or a sofa, and should there-
fore be the preferred optionwhen available. Telemetry systems differ in
the maximum distance allowed between patient and monitor for ade-
quate signal transmission [7].
3.2. Paper scales for CTG registration and viewing
The horizontal scale for CTG registration and viewing is commonly
called “paper speed” and available options are usually 1, 2, or 3 cm/min.
In many countries throughout the world 1 cm/min is selected, while in
the Netherlands it is usually 2 cm/min, and in North America and Japan
it is almost exclusively 3 cm/min. Some experts feel that 1 cm/min pro-
vides records of sufﬁcient detail for clinical analysis, and this has the ad-
vantage of reducing tracing length. Other experts feel that the small
details of CTG tracings are better evaluated using higher papers speeds.
The vertical scale used for registration and viewing may also be different,
and available alternatives are 20 or 30 bpm/cm.
The paper scales used in each center should be the ones with which
healthcare professionals are most familiar, because tracing interpreta-
tion depends on pattern recognition and these patterns may appear
very different. Inadvertent use of paper scales towhich the staff is unac-
customedmay lead to erroneous interpretations of CTG features. For ex-
ample, at 3 cm/min variability appears reduced to a clinician familiar
with the 1 cm/min scale, while it may appear exaggerated in the oppo-
site situation (see examples below).
3.3. External versus internal FHR monitoring
External FHR monitoring uses a Doppler ultrasound transducer to
detect themovement of cardiac structures. The resulting signal requires
signal modulation and autocorrelation to provide adequate qualityFig 1.Maternal heart rate monitoring in the last 9 minutes of the tracing. External fetal heart ra
graph).recordings [8]. This process results in an approximation of the true
heart rate intervals, but this is considered to be sufﬁciently accurate
for analysis. External FHRmonitoring is more prone to signal loss, to in-
advertent monitoring of the maternal heart rate (Fig. 1) [9], and to sig-
nal artefacts such as double-counting (Fig. 2) and half-counting [8],
particularly during the second stage of labor. It may also not record
fetal cardiac arrhythmias accurately.
Internal FHR monitoring using a fetal electrode (usually known as
scalp electrode, but it can also be applied to the breech) evaluates the
time intervals between successive heart beats by identifying R waves
on the fetal electrocardiogram QRS complex, and therefore measures
ventricular depolarization cycles. This method provides a more accurate
evaluation of intervals between cardiac cycles, but it is more expensive
because it requires a disposable electrode. It is very important that the
fetal electrode is only applied after a clear identiﬁcation of the presenting
part and that delicate fetal structures such as the sutures and fontanels
are avoided. Internal FHR monitoring requires ruptured membranes
and has established contraindications, mainly related to the increased
risk of vertical transmission of infections. It should not be used in patients
with active genital herpes infection, those who are seropositive to hepa-
titis B, C, D, E, or to HIV [10,11], in suspected fetal blood disorders, when
there is uncertainty about the presenting part, or when artiﬁcial rupture
of membranes is inappropriate (i.e. an unengaged presentation). Fetal
electrode placement should also preferably be avoided in very preterm
fetuses (under 32 weeks of gestation).
External FHR monitoring is the recommended initial method for
routine intrapartummonitoring, provided that a recording of acceptable
quality is obtained, i.e. that the basic CTG features can be identiﬁed.
Minimum requirements for using this method are that careful reposi-
tioning of the probe is carried out during the second stage of labor,
that in all atypical FHR tracings maternal heart rate monitoring is
ruled out (see below), and if any doubt remains, fetal auscultation,te monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom
Fig 2. Double-counting of the fetal heart rate during decelerations (arrows). External fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min
(bottom graph).
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acceptable record cannot be obtained with external monitoring or if a
cardiac arrhythmia is suspected, then internal monitoring should be
used, in the absence of the previously mentioned contraindications.
3.4. External versus internal monitoring of uterine contractions
Externalmonitoring of uterine contractions using a tocodynamometer
(toco) evaluates increased myometrial tension measured through the
abdominal wall. Incorrect placement, reduced tension applied to the
supporting elastic band, or abdominal adiposity may result in failed or
inadequate registration of contractions. In addition, this technology
only provides accurate information on the frequency of contractions.
It is not possible to extract reliable information regarding the intensity
and duration of contractions, nor on basal uterine tone.
Internal monitoring of uterine contractions using an intrauterine
catheter provides quantitative information on the intensity and duration
of contractions, as well as on basal uterine tone, but it is more expensive
as the catheter is disposable, and requires ruptured membranes.
Contraindications include uterine hemorrhage of unknown cause and
placenta previa. It may also be associatedwith a small risk of fetal injury,
placental hemorrhage, uterine perforation, and infection [12]. The
routine use of intrauterine pressure catheters has not been shown to
be associated with improved outcomes in induced and augmented
labor [13], and so it is not recommended for routine clinical use.
3.5. Simultaneous monitoring of the maternal heart rate
Simultaneous monitoring of the maternal heart rate (MHR) can be
useful in speciﬁc maternal health conditions and in caseswhere it is dif-
ﬁcult to distinguish betweenmaternal and fetal heart rates (for example
complete fetal heart block) [9]. Some CTG monitors provide thepossibility of continuous MHR monitoring, either by electrocardiogra-
phy or pulse oximetry. In some recent models, the latter technology
has been incorporated in the tocodynamometer, allowing continuous
MHR monitoring without the use of additional equipment. Providing
that the technology is available and does not cause discomfort to the
mother, simultaneous MHR monitoring should be considered when
performing continuous CTG, especially during the second stage of
labor, when tracings show accelerations coinciding with contractions
and expulsive efforts [9], or when the MHR is elevated.
3.6. Monitoring of twins
Continuous external FHR monitoring of twin gestations during
labor should preferably be performed with dual channel monitors that
allow simultaneous monitoring of both FHRs, as duplicate monitoring
of the same twin may occur and this can be picked up by observing
almost identical tracings. Somemonitors have embedded algorithms
to alarm when this situation is suspected. During the second stage of
labor, external FHR monitoring of twins is particularly affected by
signal loss, and for this reason some experts believe that the present-
ing twin should preferably be monitored internally for better signal
quality [14], if no contraindications to fetal electrode placement are
present. Other experts believe that external monitoring of both
twins is acceptable, provided that distinct and good quality FHR signals
can be obtained.
3.7. Storage of tracings
All CTG tracings need to be identiﬁedwith the patient name, place of
recording, “paper speed,” and date and time when acquisition started
and ended. In hospitals where paper CTG recordings are used, the latter
should be considered as part of the patient record and preserved as
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system needs to be in place, and all tracings should be readily available
for review by the clinical staff.
4. Analysis of tracings
CTG analysis starts with the evaluation of basic CTG features
(baseline, variability, accelerations, decelerations, and contractions)
followed by overall CTG classiﬁcation.
4.1. Evaluation of basic CTG features
4.1.1. Baseline
This is themean level of themost horizontal and less oscillatory FHR
segments. It is estimated in time periods of 10minutes and expressed in
beats per minute (bpm). The baseline value may vary between subse-
quent 10-minute sections.
In tracings with unstable FHR signals, review of previous segments
and/or evaluation of longer time periods may be necessary to estimate
the baseline [16], in particular during the second stage of labor and to
identify the fetal behavioral state of active wakefulness (Fig. 3) that
can lead to erroneously high baseline estimation.
Normal baseline: a value between 110 and 160 bpm.
Preterm fetuses tend to have values toward the upper end of this
range and post-term fetuses towards the lower end. Some experts
consider the normal baseline values at term to be between 110-
150 bpm.
Tachycardia: a baseline value above 160 bpm lasting more than
10 minutes.
Maternal pyrexia is themost frequent cause of fetal tachycardia, and it
may be of extrauterine origin or associatedwith intrauterine infection.
Epidural analgesia may also cause a rise in maternal temperatureFig 3. Fetal behavioral state of active wakefulness. This patternmay lead to erroneously high ba
itoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).resulting in fetal tachycardia [17]. In the initial stages of a non-
acute fetal hypoxemia, catecholamine secretion may also result in
tachycardia. Other less frequent causes are the administration of
beta-agonist drugs [18] (salbutamol, terbutaline, ritodrine, fenoterol),
parasympathetic blockers (atropine, scopolamine), and fetal arrhyth-
mias such as supraventricular tachycardia and atrial ﬂutter.
Bradycardia: a baseline value below 110 bpm lasting more than
10 minutes.
Values between 100 and 110 bpm may occur in normal fetuses,
especially in postdate pregnancies. Maternal hypothermia [19],
administration of beta-blockers [20], and fetal arrhythmias such as
atrioventricular block are other possible causes.
4.1.2. Variability
This refers to the oscillations in the FHR signal, evaluated as
the average bandwidth amplitude of the signal in 1-minute segments.
Normal variability: a bandwidth amplitude of 5−25 bpm.
Reduced variability: a bandwidth amplitude below 5 bpm for more
than 50 minutes in baseline segments [21] (Figs. 4 and 5), or for
more than 3 minutes during decelerations [22] (see Figs. 8 and 9).
Reduced variability can occur due to central nervous system
hypoxia/acidosis and resulting decreased sympathetic and parasym-
pathetic activity, but it can also be due to previous cerebral injury
[23], infection, administration of central nervous systemdepressants
or parasympathetic blockers. During deep sleep, variability is usually
in the lower range of normality, but the bandwidth amplitude is sel-
dom under 5 bpm. There is a high degree of subjectivity in the visual
evaluation of this parameter, and therefore careful re-evaluation is
recommended in borderline situations. Following an initially normal
CTG, reduced variability due to hypoxia is very unlikely to occur dur-
ing labor without preceding or concomitant decelerations and a rise
in the baseline.seline estimation if it is identiﬁed at the top of accelerations. External fetal heart rate mon-
Fig 4. Reduced variability. External fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
Fig 5. Reduced variability. The baseline is affected by contractions causing decreases in fetal heart rate that are close to fulﬁlling the criteria for decelerations, but the bandwidth remains
reduced. Internal fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
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ceeding 25 bpm lasting more than 30 minutes (Fig. 6).
The pathophysiology of this pattern is incompletely understood, but
it may be seen linked with recurrent decelerations, when hypoxia/
acidosis evolves very rapidly. It is presumed to be caused by fetal
autonomic instability/hyperactive autonomic system [24].
4.1.3. Accelerations
Abrupt (onset to peak in less than 30 seconds) increases in FHR
above the baseline, of more than 15 bpm in amplitude, and lasting
more than 15 seconds but less than 10 minutes.
Most accelerations coincidewith fetalmovements and are a sign of a
neurologically responsive fetus that does not have hypoxia/acidosis.
Before 32 weeks of gestation, their amplitude and frequency may be
lower (10 seconds and 10 bpm of amplitude). After 32−34 weeks,
with the establishment of fetal behavioral states, accelerations
rarely occur during periods of deep sleep, which can last up to
50 minutes [21]. The absence of accelerations in an otherwise normal
intrapartumCTG is of uncertain signiﬁcance, but it is unlikely to indicate
hypoxia/acidosis. Accelerations coinciding with uterine contractions,
especially in the second stage of labor, suggest possible erroneous re-
cording of thematernal heart rate, since the FHRmore frequently decel-
erates with a contraction, while the maternal heart rate typically
increases [9].
4.1.4. Decelerations
Decreases in the FHR below the baseline, of more than 15 bpm in
amplitude, and lasting more than 15 seconds.
Early decelerations: decelerations that are shallow, short-lasting,
with normal variability within the deceleration and are coincident
with contractions. They are believed to be caused by fetal head com-
pression [25] and do not indicate fetal hypoxia/acidosis.Fig 6. Increased variability: saltatory pattern. Internal fetal heart rate monitoring at 1 cmVariable decelerations (V-shaped): decelerations that exhibit a
rapid drop (onset to nadir in less than 30 seconds), good variability
within the deceleration, rapid recovery to the baseline, varying
size, shape, and relationship to uterine contractions (Fig. 7).
Variable decelerations constitute the majority of decelerations dur-
ing labor, and they translate a baroreceptor-mediated response to
increased arterial pressure, as occurs with umbilical cord compres-
sion [26]. They are seldom associated with an important degree of
fetal hypoxia/acidosis, unless they evolve to exhibit a U-shaped com-
ponent, reduced variabilitywithin the deceleration (see late deceler-
ations below), and/or their individual duration exceeds 3 minutes
[22,27] (see prolonged decelerations below).
Late decelerations (U-shaped and/or with reduced variability):
decelerations with a gradual onset and/or a gradual return to
the baseline and/or reduced variability within the deceleration
(Fig. 8). Gradual onset and return occurs when more than
30 seconds elapses between the beginning/end of a deceleration
and its nadir. When contractions are adequately monitored, late de-
celerations start more than 20 seconds after the onset of a contrac-
tion, have a nadir after the acme, and a return to the baseline after
the end of the contraction.
These decelerations are indicative of a chemoreceptor-mediated re-
sponse to fetal hypoxemia [25,27]. In the presence of a tracing with
no accelerations and reduced variability, the deﬁnition of late decel-
erations also includes those with an amplitude of 10−15 bpm.
Prolonged decelerations: lasting more than 3 minutes.
These are likely to include a chemoreceptor-mediated component and
thus to indicate hypoxemia. Decelerations exceeding 5 minutes, with
FHR maintained at less than 80 bpm and reduced variability within
the deceleration (Fig. 9), are frequently associated with acute fetal
hypoxia/acidosis [22,28–30] and require emergent intervention./min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
Fig 7. Variable decelerations. Internal fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
Fig 8. Late decelerations in the second half of the tracing. External fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
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Fig 9. Prolonged deceleration. External fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
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A regular, smooth, undulating signal, resembling a sine wave, with
an amplitude of 5−15 bpm, and a frequency of 3−5 cycles per minute.
This pattern lasts more than 30 minutes, and coincides with absent
accelerations (Fig. 10).
The pathophysiological basis of the sinusoidal pattern is incompletely
understood, but it occurs in association with severe fetal anemia, as is
found in anti-D alloimmunization, fetal-maternal hemorrhage, twin-to-
twin transfusion syndrome, and ruptured vasa previa. It has also been de-
scribed in cases of acute fetal hypoxia, infection, cardiac malformations,
hydrocephalus, and gastroschisis [31].
4.1.6. Pseudosinusoidal pattern
A pattern resembling the sinusoidal pattern, but with a more jagged
“saw-tooth” appearance, rather than the smooth sine-wave form
(Fig. 11). Its duration seldom exceeds 30minutes and it is characterized
by normal patterns before and after.
This pattern has been described after analgesic administration to the
mother, and during periods of fetal sucking and othermouthmovements
[32]. It is sometimes difﬁcult to distinguish the pseudosinusoidal pattern
from the true sinusoidal pattern, leaving the short duration of the former
as the most important variable to discriminate between the two.
4.1.7. Fetal behavioral states
This refers to periods of fetal quiescence reﬂecting deep sleep
(no eye movements), alternating with periods of active sleep (rapid
eye movements) and wakefulness [33,34]. The occurrence of different
behavioral states is a hallmark of fetal neurological responsiveness
and absence of hypoxia/acidosis. Deep sleep can last up to 50 minutes
[21] and is associated with a stable baseline, very rare accelerations,
and borderline variability. Active sleep is the most frequent behavioral
state, and is represented by a moderate number of accelerations andnormal variability. Active wakefulness is rarer and represented by a
large number of accelerations and normal variability (Fig. 1). In the lat-
ter pattern, accelerations may be so frequent as to cause difﬁculties in
baseline estimation (see Fig. 1). Transitions between the different pat-
terns become clearer after 32−34 weeks of gestation, consequent to
fetal nervous system maturation.
4.1.8. Contractions
These are bell-shaped gradual increases in the uterine activity signal
followed by roughly symmetric decreases, with 45−120 seconds in
total duration.
Contractions are essential for the progression of labor, but they com-
press the vessels running inside the myometrium and may transiently
decrease placental perfusion and/or cause umbilical cord compression
[35]. With the tocodynamometer, only the frequency of contractions
can be reliably evaluated, but increased intensity and duration can
also contribute to FHR changes.
Tachysystole: This represents an excessive frequency of contrac-
tions and is deﬁned as the occurrence of more than ﬁve contractions
in 10 minutes, in two successive 10-minute periods, or averaged
over a 30-minute period.
5. Tracing classiﬁcation
Tracing classiﬁcation requires a previous evaluation of basic CTG fea-
tures (see above). Tracings should be classiﬁed into one of three classes:
normal, suspicious, or pathological, according to the criteria presented
in Table 1. Other classiﬁcation systems including a larger number of
tiers are recommended by some experts [36,37]. Due to the changing
nature of CTG signals during labor, re-evaluation of the tracing should
be carried out at least every 30 minutes.
Fig 10. Sinusoidal pattern. External fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
Fig 11. Pseudosinusoidal pattern. External fetal heart rate monitoring at 1 cm/min (top graph), 2 cm/min (middle graph), and 3 cm/min (bottom graph).
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Table 1
Cardiotocography classiﬁcation criteria, interpretation, and recommended management.a
Normal Suspicious Pathological
Baseline 110−160 bpm Lacking at least one characteristic of normality, but
with no pathological features
b100 bpm
Variability 5−25 bpm Lacking at least one characteristic of normality, but
with no pathological features
Reduced variability, increased variability, or sinusoidal
pattern
Decelerations No repetitiveb decelerations Lacking at least one characteristic of normality, but
with no pathological features
Repetitiveb late or prolonged decelerations during
N30 min or 20 min if reduced variability, or one
prolonged deceleration with N5 min
Interpretation Fetus with no hypoxia/acidosis Fetus with a low probability of having
hypoxia/acidosis
Fetus with a high probability of having hypoxia/acidosis
Clinical management No intervention necessary to improve
fetal oxygenation state
Action to correct reversible causes if identiﬁed,
close monitoring or additional methods to evaluate
fetal oxygenation [49]
Immediate action to correct reversible causes,
additional methods to evaluate fetal oxygenation
[49], or if this is not possible expedite delivery. In
acute situations (cord prolapse, uterine rupture, or
placental abruption) immediate delivery should be
accomplished.
a The presence of accelerations denotes a fetus that does not have hypoxia/acidosis, but their absence during labor is of uncertain signiﬁcance.
b Decelerations are repetitive in nature when they are associated with more than 50% of uterine contractions [29].
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Several factors, including gestational age and medication adminis-
tered to themother, can affect FHR features (see above), so CTG analysis
needs to be integrated with other clinical information for a comprehen-
sive interpretation and adequate management. As a general rule, if the
fetus continues tomaintain a stable baseline and a reassuring variability,
the risk of hypoxia to the central organs is very unlikely. However, the
general principles that should guide clinical management are outlined
in Table 1.
7. Action in situations of suspected fetal hypoxia/acidosis
When fetal hypoxia/acidosis is anticipated or suspected (suspicious
and pathological tracings), and action is required to avoid adverse neo-
natal outcome, this does not necessarily mean an immediate cesarean
delivery or instrumental vaginal delivery. The underlying cause for the
appearance of the pattern can frequently be identiﬁed and the situation
reversed, with subsequent recovery of adequate fetal oxygenation and
the return to a normal tracing.
Excessive uterine activity is themost frequent cause of fetal hypoxia/
acidosis [35] and it can be detected by documenting tachysystole in the
CTG tracing and/or palpating the uterine fundus. It can usually be re-
versed by reducing or stopping oxytocin infusion, removing adminis-
tered prostaglandins if possible, and/or starting acute tocolysis with
beta-adrenergic agonists (salbutamol, terbutaline, ritodrine) [38–40],
atosiban [41], or nitroglycerine [42]. During the second stage of labor,
maternal pushing efforts can also contribute to fetal hypoxia/acidosis
and the mother can be asked to stop pushing until the situation
is reversed.
Aortocaval compression can occur in the supine position and lead to
reduced placental perfusion. Excessive uterine activitymay also be asso-
ciated with the supine position [43,44], possibly due to the stimulation
of the sacral plexus by the uterine weight. In these cases, turning the
mother to her side is frequently followed by normalization of the CTG
pattern. Transient cord compression is another common cause of CTG
changes (variable decelerations), and these can sometimes be reverted
by changing thematernal position or by performing amnioinfusion [45].
Sudden maternal hypotension can also occur during labor, usually
after epidural or spinal analgesia [46], and it is usually reversible by
rapid ﬂuid administration and/or an intravenous ephedrine bolus.
Other less frequent complications affecting the maternal respiration,
maternal circulation, placenta, umbilical cord, or the fetal circulation
can also result in fetal hypoxia/acidosis [35], and their management is
beyond the scope of this document.
Oxygen administration to themother is widely used with the objec-
tive of improving fetal oxygenation and consequently normalizing CTGpatterns, but there is no evidence from randomized clinical trials that
this intervention, when performed in isolation, is effectivewhenmater-
nal oxygenation is adequate [47]. Intravenous ﬂuids are also commonly
used for the purpose of improving CTG patterns, but again there is no
evidence from randomized clinical trials to suggest that this interven-
tion is effective in normotensive women [48].
Good clinical judgement is required to diagnose the underlying
cause for a suspicious or pathological CTG, to judge the reversibility of
the conditions with which it is associated, and to determine the timing
of delivery, with the objective of avoiding prolonged fetal hypoxia/
acidosis, as well as unnecessary obstetric intervention. Additional
methodsmay be used to evaluate fetal oxygenation [49]. When a suspi-
cious or worsening CTG pattern is identiﬁed, the underlying cause
should be addressed before a pathological tracing develops. If the situa-
tion does not revert and the pattern continues to deteriorate, consider-
ation needs to be given for further evaluation or rapid delivery if a
pathological pattern ensues.
During the second stage of labor, due to the additional effect of ma-
ternal pushing, hypoxia/acidosis may develop more rapidly. Therefore,
urgent action should be undertaken to relieve the situation, including
discontinuation of maternal pushing, and if there is no improvement,
delivery should be expedited.
8. Limitations of cardiotocography
Cardiotocography has well-documented limitations, and it is neces-
sary to be aware of these for safe use of the technology.
It has beenwell demonstrated that CTG analysis is subject to consid-
erable intra- and interobserver disagreement, even when experienced
clinicians use widely accepted guidelines [50–52]. The main aspects
that are prone to observer disagreement are the identiﬁcation and clas-
siﬁcation of decelerations, the evaluation of variability [51], and the
classiﬁcation of tracings as suspicious and pathological [51,52]. The sub-
jectivity of observer analysis has also been demonstrated in retrospec-
tive audit of tracings, where CTG features are frequently assessed to be
more abnormal in cases with known adverse neonatal outcome [53].
Many studies have evaluated the ability of suspicious and patholog-
ical CTGs to predict the occurrence of hypoxia/acidosis. Different CTG in-
terpretation criteria, different intervals between tracing abnormality
and birth, and different criteria to deﬁne adverse outcome have been
used, resulting in mixed ﬁndings [54]. However, it is recognized that
hypoxia/acidosis has not been documented shortly after a normal CTG
tracing. On the other hand, suspicious and pathological tracings have a
limited capacity to predict metabolic acidosis and low Apgar scores,
i.e. a large percentage of cases with suspicious and pathological tracings
do not have these outcomes [54].While there is a strong association be-
tween certain FHR patterns and hypoxia/acidosis, their capacity to
23D. Ayres-de-Campos et al. / International Journal of Gynecology and Obstetrics 131 (2015) 13–24discriminate between newborns with or without metabolic acidosis is
limited. Thus, they are sensitive indicators, but have a low speciﬁcity
and low positive predictive value. However, it should not be forgotten
that the aim of intrapartum fetal monitoring is to identify situations
that precede hypoxia/acidemia so as to avoid fetal injury. The subjectiv-
ity of CTG interpretation and the fact that hypoxia is a continuum that
may not reach the threshold ofmetabolic acidosis or injury are probably
important contributing factors to these limitations.
A large number of randomized controlled trials have been conducted
comparing continuous CTG monitoring with intermittent auscultation
as screening methods for fetal hypoxia/acidosis during labor, in both
low- and high-risk women [1,2]. However, these trials took place in
the 1970s, 1980s, and early 1990s, and used different CTG interpretation
criteria, so it is difﬁcult to establish how their results relate to current
clinical practice. With these limitations in mind, they indicate a limited
beneﬁt of continuous CTG for fetal monitoring in all women during
labor, as the only signiﬁcant improvement was a 50% reduction in neo-
natal seizures (hypoxic-ischemic encephalopathy was not evaluated in
most trials), and no differences were found in the incidences of overall
perinatal mortality and cerebral palsy. However, it is widely recognized
that the trials were underpowered to detect differences in these out-
comes [3]. Only a small proportion of perinatal deaths and cerebral
palsies are caused by intrapartum hypoxia/acidosis, so a large number
of cases are needed to show any beneﬁt. On the other hand, continuous
CTG was associated with a 63% increase in cesarean delivery and a 15%
increase in instrumental vaginal deliveries [1].
Unnecessary obstetric intervention confers additional risks for the
mother and newborn [55,56], and the former may result from poor
CTG interpretation, limited knowledge of the pathophysiology of fetal
oxygenation, and inadequate clinical management. It is recognized
that, for consistent implementation, clinical guidelines need to be
as simple and objective as possible, to allow rapid decision-making
even in complex and stressful situations. In addition, regular and struc-
tured training of the labor ward staff is essential to ensure proper use of
this technology.
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